Literature DB >> 26243228

Outcome Following Decompressive Hemicraniectomy for Malignant Cerebral Infarction: Ethical Considerations.

Stephen Honeybul1, Kwok Ming Ho2, Grant Gillett2.   

Abstract

Entities:  

Keywords:  brain; decompressive craniectomy; ethics; outcome; stroke

Mesh:

Year:  2015        PMID: 26243228     DOI: 10.1161/STROKEAHA.115.010078

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


× No keyword cloud information.
  6 in total

1.  Attitudes of Nurses Toward Disability and Treatment in Space-Occupying Middle Cerebral Artery Stroke.

Authors:  Hermann Neugebauer; Flora Malakou; Ingo Uttner; Melitta Köpke; Eric Jüttler
Journal:  Neurocrit Care       Date:  2019-02       Impact factor: 3.210

2.  Attitudes of Patients and Relatives Toward Disability and Treatment in Malignant MCA Infarction.

Authors:  Hermann Neugebauer; Matthias Schnabl; Dorothée Lulé; Peter U Heuschmann; Eric Jüttler
Journal:  Neurocrit Care       Date:  2017-04       Impact factor: 3.210

3.  A simple prediction score system for malignant brain edema progression in large hemispheric infarction.

Authors:  KwangWook Jo; Suhas S Bajgur; Hoon Kim; Huimahn A Choi; Pil-Woo Huh; Kiwon Lee
Journal:  PLoS One       Date:  2017-02-08       Impact factor: 3.240

4.  Clinical significance and efficacy analysis of atorvastatin in the treatment of patients with cerebral infarction and aspiration pneumonia.

Authors:  Bing Wei; Yugeng Liu
Journal:  Exp Ther Med       Date:  2018-10-04       Impact factor: 2.447

Review 5.  Decompressive craniotomy for malignant middle cerebral artery infarction: The quest for an African perspective.

Authors:  Dinesh Naidoo
Journal:  Surg Neurol Int       Date:  2021-05-03

6.  A study of the opinions of Swedish healthcare personnel regarding acceptable outcome following decompressive hemicraniectomy for ischaemic stroke.

Authors:  Magnus Olivecrona; Stephen Honeybul
Journal:  Acta Neurochir (Wien)       Date:  2017-11-04       Impact factor: 2.216

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.